For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Burroughs Wellcome Co.

USPTO Granted Patents = 521

Trademarks = 24

Forward Citations = 6,657

Loading Chart...

Loading Chart...

358 inventors (with patents filed for the assignee):

Kenneth W Bair (45 out of 45 patents)

Thomas A Krenitsky (27 out of 40 patents)

Janet L Rideout (23 out of 63 patents)

4. John Frederick Batchelor (19 out of 19 patents)

5. Harold Francis Hodson (15 out of 34 patents)

6. Susan Mary Daluge (15 out of 46 patents)

7. Samuel Wilkinson (15 out of 16 patents)

8. Robert W Morrison, Jr (14 out of 14 patents)

9. Virgil L Styles (14 out of 16 patents)

10. Sandra N Lehrman (14 out of 18 patents)

11. Phillip A Furman (13 out of 16 patents)

12. David Walter Barry (13 out of 25 patents)

13. William R Mallory (12 out of 12 patents)

14. Martha H St Clair (12 out of 16 patents)

15. Lawrence Edward Brieaddy (11 out of 17 patents)

Core Competencies:

Chimeric Antibody

Fusogenic Liposomes

Recombinant Proteins

Therapeutic Nucleosides

Indole Derivatives

Neuromuscular Blocking Agents

Antiviral Compositions

Pharmaceutical Formulations

Immunoglobulins

Aryl Hydroxyurea Compounds

Heterocyclic Compounds

Anti-Atherosclerotic Compounds

521 patents: Sort by Forward Citations

1. 7098006 - Chimeric antibody, pharmaceutical composition and process of its production (2006-08-29),

2. 5985318 - Fusogenic liposomes that are free of active neuraminidase (1999-11-16),

3. 5654403 - Immunoglobulins stabilized with a chelator of copper ions (1997-08-05),

4. 5644036 - Purified immunoglobulin (1997-07-01),

5. 5597708 - Cloning of a malarial gene (1997-01-28),

6. D376847 - Pharmaceutical tablet (1996-12-24),

7. 5547976 - Further indole derivatives with antiviral activity (1996-08-20),

8. 5547664 - Expression of recombinant proteins in attenuated bacteria (1996-08-20),

9. 5545405 - Method for treating a mammal suffering from cancer with a (1996-08-13),

10. 5545404 - Method for treating a mammal suffering from a T-cell medicated disorder (1996-08-13),

11. 5545403 - Method for treating a mammal by administering a CHO-glycosylated antibody (1996-08-13),

12. 5534535 - Therapeutic nucleosides (1996-07-09),

13. 5512269 - Method of treating retained pulmonary secretions (1996-04-30),

14. 5508310 - Immunopotentiatory agents and physiologically acceptable salts thereof (1996-04-16),

15. 5495944 - Bottle with tamper evident wrapping (1996-03-05),

Burroughs Wellcome Co. is a pharmaceutical company with a rich history of over 100 years. With a focus on research and development, we strive to discover innovative solutions to global health challenges. Our portfolio includes a wide range of medicines and vaccines that are trusted by healthcare professionals worldwide. Visit our website to learn more about our company and the transformative work we do in improving the lives of people around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

521 Patents

#1 in Research Triangle Park, NC

#26 in North Carolina

#907 in US

#1,814 in the World

Research Triangle Park, NC, United States of America

Burroughs Wellcome Co.

Forward Citations = 6,657

358 inventors:

Kenneth W Bair (45 out of 45 patents)

Thomas A Krenitsky (27 out of 40 patents)

Janet L Rideout (23 out of 63 patents)

4. John Frederick Batchelor (19 out of 19 patents)

5. Harold Francis Hodson (15 out of 34 patents)

Please report any incorrect information to support@idiyas.com

Loading…